VISEN Pharmaceuticals (HKG:2561)
Hong Kong · Delayed Price · Currency is HKD 19.04
-0.06 (-0.31%)
Sep 18, 2026, 4:08 PM HKT
VISEN Pharmaceuticals Market Cap
VISEN Pharmaceuticals has a market cap or net worth of 2.08 billion as of September 18, 2026. Its market cap has decreased by -55.78% in one year.
Market Cap
2.08B
Enterprise Value
1.70B
Revenue
39.32M
Ranking
n/a
PE Ratio
n/a
Stock Price
19.04
ChartMarket Cap Chart
Since March 21, 2025, VISEN Pharmaceuticals's market cap has decreased from 7.20B to 2.08B, a decrease of -71.08%. That is a compound annual growth rate of -56.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 2.08B | -39.59% |
| Dec 31, 2025 | 3.44B | -52.13% |
| Mar 21, 2025 | 7.20B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Xuanzhu Biopharmaceutical | 4.71B |
| CF PharmTech | 4.32B |
| Edding Genor Group Holdings | 3.28B |
| Hua Medicine (Shanghai) | 2.33B |
| CPBIO Holding Company | 2.13B |
| Jacobson Pharma Corporation | 1.93B |
| Dawnrays Pharmaceutical (Holdings) | 1.48B |
| Golden Throat Holdings Group Company | 1.44B |